Understanding the evidence base prevents overestimating results
Cigna is cutting weight-loss GLP-1 coverage for its own employees, and that makes the obesity drug boom look less simple for everyone building around it
The research is compelling, but its only part of the full picture The Dark Side of Ozempic (That People Arent Talking About) What you dont always hear online: Muscle loss if youre not strength training or eating enough protein Digestive issues (nausea, constipation, slowed motility) Nutrient deficiencies over time Rebound weight gain if you stop the medication without a supportive lifestyle in place Theres also the ethical side: people who genuinely need these meds cant always access them due to demand from off-label use
The same 2020 research review that found no evidence of benefits identified numerous serious adverse effects, ranging from uncomfortable to life-threatening
However, if any unusual or severe symptoms occur, seek medical attention immediately
however, clinical situations such as hospitalizations for diabetic foot infection when revascularization is not required, or simply ulcers in patients with PAD managed outpatiently, are not considered in the definition of MALEour analysis primarily focused on lower limb amputation and adverse events potentially leading to amputation as the main events